Published in Cancer Weekly, August 20th, 2002
Researchers set out to explore the cause of treatment failures following radiation therapy in some prostate cancer patients. Focusing in on the p53 gene, they hypothesized that the active or inactive state of the gene product may play a role in whether the cancer is successfully treated by radiation.
When normal, the p53 gene product has been shown to be a tumor killer whose natural...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.